Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Filtered Value Type Gene Rank green description Interaction Map Network Comparison Type red network_comparison
Results: HTML CSV LaTeX
Showing element 51 to 100 of 77072 in total
Filtered: 0
Value Type: Measured

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
115.385\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fk506-binding protein 6 (ec 5.2.1.8) (peptidyl-prolyl cis-trans isomerase) (ppiase) (rotamase) (36 kda fk506 binding protein) (fkbp- 36) (immunophilin fkbp36). [source:swissprot;acc:o75344]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8.11997\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
14.21\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
3953.32\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2961.07\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
992.25\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
6.50325\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cyclin h (mo15-associated protein) (p37) (p34). [source:swissprot;acc:p51946]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
130.512\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
20.0687\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5900000\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
12125.1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
10817.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1308\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
16295.1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho gdp-dissociation inhibitor 1 (rho gdi 1) (rho-gdi alpha). [source:swissprot;acc:p52565]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
17235.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
940.4\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
156\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial precursor (cybs) (succinate-ubiquinone reductase membrane anchor subunit) (qps2) (cii-4) (succinate dehydrogenase complex subunit d) (succinate-ubiquinone oxidoreductase cytochrome b small subunit). [source:swissprot;acc:o14521]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15.6\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
2740.13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
485.286\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.64642\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
4823.8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myotubularin related protein 8. [source:refseq;acc:nm\_017677]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
3888.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
935.2\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
6685.11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin-like protein smt3b (sentrin 2) (hsmt3). [source:swissprot;acc:p55855]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
7981.68\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1296.57\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
704.5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein kinase, lysine deficient 3. [source:refseq;acc:nm\_020922]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.636\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
7572.88\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nif3-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 1) (my018 protein) (mds015). [source:swissprot;acc:q9gzt8]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
8852.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1279.52\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
9808\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
vps10 domain-containing receptor sorcs1 precursor (hsorcs). [source:swissprot;acc:q8wy21]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
8926.33\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
881.67\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
14.8103\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.26667\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
5837.83\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ena/vasodilator stimulated phosphoprotein-like protein (ena/vasp-like protein). [source:swissprot;acc:q9ui08]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
4959.42\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
878.41\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
12473\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ba271b5.1 (similar to ribosomal protein s7). [source:sptrembl;acc:q9h1s9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
11223\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1250\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp-regulated phosphoprotein 19 (arpp-19) [contains: camp-regulated phosphoprotein 16 (arpp-16)]. [source:swissprot;acc:p56211]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.21053\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
801\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
14167\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
15411.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1244.3\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.3268\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
2407.27\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
3205.98\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
798.71\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
2804\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1211\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
82\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
8200000\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
139\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
570\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4.10072\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
3169.35\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
2376\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
793.35\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
7608\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
8763\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1155\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
17.6611\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
syntaxin 10 (syn10). [source:swissprot;acc:o60499]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
118.878\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6.73106\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
434.911\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
111.278\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.90833\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
3321.82\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
spectrin beta chain, brain 4 (spectrin, non-erythroid beta chain 4) (beta-v spectrin) (bspecv). [source:swissprot;acc:q9nrc6]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
4088.01\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
766.19\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
5690.63\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
swi/snf related, matrix associated, actin dependent regulator of chromatin subfamily d member 1 (swi/snf complex 60 kda subunit) (brg1- associated factor 60a). [source:swissprot;acc:q96gm5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
6804.88\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1114.25\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
carbohydrate (n-acetylglucosamine 6-o) sulfotransferase 6; macular dystrophy, corneal, 1; carbohydate sulfotransferase 6; corneal n-acetylglucosamine 6-sulfotransferase. [source:refseq;acc:nm\_021615]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3700000\vspace{3pt}}\\\cline{3-4}\cline{6-7}
&&\parbox{\wcC}{\vspace{3pt}\noindent
similar to lysozyme c-1 (1,4-beta-n-acylmuramidase c, ec 3.2.1.17). [source:refseq;acc:nm\_032517]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
60\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6000000\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
4100.24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sorbitol dehydrogenase (ec 1.1.1.14) (l-iditol 2-dehydrogenase). [source:swissprot;acc:q00796]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
4821.65\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
721.41\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
30022.4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription initiation factor tfiid 135 kda subunit (tafii-135) (tafii135) (tafii-130) (tafii130). [source:swissprot;acc:o00268]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
31122\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1099.6\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carbohydrate (n-acetylglucosamine-6-o) sulfotransferase 2; carbohydrate (chondroitin 6/keratan) sulfotransferase 2. [source:refseq;acc:nm\_004267]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3700000\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5900000\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
5540.2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
6596.23\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1056.03\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
5584.69\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase h precursor (ec 3.4.17.10) (cph) (carboxypeptidase e) (cpe) (enkephalin convertase) (prohormone processing carboxypeptidase). [source:swissprot;acc:p16870]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
6302.92\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
718.23\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.26667\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
493\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cathepsin z precursor (ec 3.4.22.-) (cathepsin x) (cathepsin p). [source:swissprot;acc:q9ubr2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
154\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.2013\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
2208.1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
3233.86\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1025.76\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
4550.64\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein family member 3 (wasp-family protein member 3) (verprolin homology domain-containing protein 3). [source:swissprot;acc:q9upy6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
5202.89\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
652.25\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
39.8063\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim domain binding 1; carboxy terminal lim domain protein 2; lim domain-binding factor-1. [source:refseq;acc:nm\_003893]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.6208\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3.15402\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
773\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase iia (ec 3.6.1.-). [source:swissprot;acc:o75110]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
148\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5.22297\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
1377\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
459.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
917.5\vspace{3pt}}\\\cline{2-4}\cline{6-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
5220.6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
4589.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
630.82\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/